COST picto_medicine
BMBS
Members Area
 
Homepage
Domains and Actions
>BMBS
>Actions
>Meetings
>in Detail
>DC Members
>DC Rapporteurs
>DC BMBS Liaisons
Search Actions
GO TOP GO BOTTOM
CE EU
COST is supported by the EU RTD Framework Programme
 
GO BOTTOM GO BOTTOM
GO TOP GO BOTTOM
ESF
ESF provides the COST Office through a European Commission contract
 
GO BOTTOM GO BOTTOM
GO TOP GO BOTTOM
CE EU
The Council of the European Union provides the COST Secretariat
 
GO BOTTOM GO BOTTOM

Action BM0702: Urine and Kidney Proteomics


 
Action overview

Printable version

The main objective of the Action is to to catalyze translational research in kidney diseases via standardization in all aspects of urine and kidney proteomics analysis from specimen collection and databasing up to data processing and analysis.
Renal diseases constitute a major health threat in all societies. Proteomics is the large-scale analysis of the proteins of biological samples. Application of pro-teomics methodo-logies in the investigation of renal diseases will catalyze the development of optimal diagnostic and prognostic tests. Despite preliminary successful efforts, the interactions between the multidisciplinary teams of scientists working on kidney diseases and proteomics are still limited in Europe. EuroKUP will foster the generation of a strong and growing multi disciplinary network of scientists from at least 20 European countries, focusing on renal and urine proteomics. The objectives of the Action focus on the identification of reference clinical centres for major kidney diseases and establishment of uniform clinical databases, standardization and optimization of procedures, integration of data to systems biology approaches and dissemination of information for application to diagnostic/prognostic procedures. Multiple scientific, technological and societal benefits to the European Union are expected, including but not limited to setting the urgently needed standards for clinical proteomics and translational research and improving the clinical situation in chronic renal diseases.

Keywords: Kidney, Urine, Clinical Proteomics, Standardization, Network



Domain : Biomedicine and Molecular Biosciences
Action title : Urine and Kidney Proteomics



Action details Parties
  Country Date Status
MoU : 243/07
CSO Approval date : 16/11/2007
Entry into force : 09/01/2008
End of Action : 18/05/2012
Austria 11/04/2008 Confirmed
Belgium 09/01/2008 Confirmed
Cyprus 17/04/2008 Confirmed
Czech Republic 17/07/2008 Confirmed
Denmark 07/02/2008 Confirmed
Finland 19/03/2008 Confirmed
Former Yugoslav Republic of Macedonia 07/02/2008 Confirmed
France 17/01/2008 Confirmed
Germany 09/01/2008 Confirmed
Greece 09/01/2008 Confirmed
Ireland 04/06/2009 Confirmed
Italy 12/03/2008 Confirmed
Netherlands 17/03/2008 Confirmed
Norway 26/05/2008 Confirmed
Poland 11/01/2008 Confirmed
Serbia 08/02/2010 Confirmed
Spain 09/01/2008 Confirmed
Sweden 09/06/2008 Confirmed
Switzerland 15/02/2008 Confirmed
United Kingdom 09/01/2008 Confirmed
Total 20  
 
Non COST Institutions
Institution NameCountry
Baker IDI Heart and Diabetes Institute Australia
 
Intentions to accept the MoU
Country   Status
Bulgaria Intention
Lithuania Intention
Total 2  


Action Web Site: http://www.eurokup.org

Notice board

More Information can be obtained through the website :
http://www.eurokup.org

or  by contacting the Chair of the Action :
Dr Antonia VLAHOU

Rapporteur :
Prof. Barbara CANNON

Science Officer :
Dr Magdalena RADWANSKA

Administrative Officer :
Ms Gabriela CRISTEA



Legal Notice | Accessibility | Sitemap top